Go-Evac Alternatives Compared
| Go-Evac (polyethylene glycol 3350 with electrolytes) | MiraLAX (polyethylene glycol 3350) | Polyethylene glycol 3350 |
|
|---|
| Go-Evac (polyethylene glycol 3350 with electrolytes) | MiraLAX (polyethylene glycol 3350) | Polyethylene glycol 3350 |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bowel Preparation, Constipation - Chronic, Gastrointestinal Decontamination. Go-Evac may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Irritable Bowel Syndrome with Constipation, Constipation - Acute, Constipation, Bowel Preparation, Irritable Bowel Syndrome. MiraLAX may also be used for purposes not listed in this... View more |
Prescription and OTC
Prescribed for Irritable Bowel Syndrome with Constipation, Constipation - Acute, Constipation, Bowel Preparation, Irritable Bowel Syndrome. Polyethylene glycol 3350 may also be used for purposes not... View more |
Related suggestions Bowel Preparation
|
|||||||
| More about (polyethylene glycol 3350 with electrolytes) | More about MiraLAX (polyethylene glycol 3350) | More about Polyethylene glycol 3350 | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
MiraLAX has an average rating of 7.2 out of 10 from a total of 263 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 22% reported a negative effect. |
Polyethylene glycol 3350 has an average rating of 7.1 out of 10 from a total of 351 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Go-Evac side effects |
View all MiraLAX side effects |
|||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Polyethylene glycol 3350 prices |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
N/A |
|
||||||||
| Brand Names | ||||||||||
| Other polyethylene glycol 3350 with electrolytes brands include: Clenz-Lyte, Co-Lav, Colonic Lavage Solution, Colyte, GaviLyte-C, GaviLyte-G, GaviLyte-H, GaviLyte-N, GoLYTELY, MoviPrep, NuLYTELY, PEG-3350 with Electolytes, Plenvu, Suflave, TriLyte View more | Other polyethylene glycol 3350 brands include: ClearLax, GaviLAX, Gialax, GlycoLax, HealthyLax, PEG3350, Purelax, SunMark ClearLax | ClearLax, GaviLAX, Gialax, GlycoLax, HealthyLax, MiraLAX, PEG3350, Purelax, SunMark ClearLax View more | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 397 drugs are known to interact with Go-Evac:
|
A total of 224 drugs are known to interact with MiraLAX:
|
A total of 224 drugs are known to interact with Polyethylene glycol 3350:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
N/A |
February 18, 1999 |
N/A |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
|
N/A |
||||||||||
| Professional Resources | ||||||||||
|
N/A |
||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.